Denmark · 
Who invested in Neumirna Therapeutics?
Neumirna Therapeutics's investors include Vivo Capital and Innovestor.
Denmark · Series A startup
Who invested in Neumirna Therapeutics
Funding summaryUpdated 26 Oct 2026
$21Mraised across 1 round since 2025, from 1 source
- Latest round
- Series A, $21MJan 2025
- Investors
- 2
The rounds
- Jan 2025
Founders and team
From Neumirna Therapeutics's own website: 1 founder, 4 on the team.
Lars Hellerung ChristiansenCo-Founder
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists Neumirna Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Neumirna Therapeutics
How much has Neumirna Therapeutics raised?
Neumirna Therapeutics has raised $21M across 1 round since 2025.
When did Neumirna Therapeutics last raise?
Neumirna Therapeutics's most recent round was a Series A of $21M in Jan 2025.
What was Neumirna Therapeutics's biggest round?
Its most recent round, $21M in Jan 2025, is also its largest on record.
Who backed Neumirna Therapeutics first?
Neumirna Therapeutics's first round on record, in Jan 2025, was backed by Vivo Capital and Innovestor.
What stage is Neumirna Therapeutics at?
Neumirna Therapeutics's latest named round is a Series A, in Jan 2025.
Where is Neumirna Therapeutics based?
Neumirna Therapeutics is based in Denmark.
Companies like Neumirna Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.